Open access · CC-BY
via OpenAlex
Inflammatory and Immune Biomarkers in Mood Disorders: From Mechanistic Pathways to Clinical Translation
Mario Pinzi, Andrea M. Fagiolini, Despoina Koukouna, Giacomo Gualtieri, Maria Beatrice Rescalli, Caterina Pierini, Simone Pardossi, Benjamin Patrizio, Alessandro Cuomo
Cells · 2025 · ▲ 45 citations
Abstract
Over the past two decades, immune-inflammatory dysregulation has emerged as a central paradigm in the biology of mood disorders. Patients with major depression (MDD) and bipolar disorder (BD) frequently display low-grade systemic inflammation. Elevated C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) identify clinically relevant subgroups of patients characterized by greater severity, cognitive impairment, and poor treatment response. Changes in the gut microbiota and disruptions of the blood-brain barrier (BBB) act as important gateways through which systemic immune activity can influence the brain. At the intracellular level, pattern-recognition receptors activate convergent hubs including NF-κB, JAK/STAT, and MAPK cascades, while the NLRP3 inflammasome integrates mitochondrial dysfunction(definition) and oxidative stress with IL-1β release and pyroptosis. These pathways converge on glial dysregulation, impaired BDNF/TrkB signaling, and kynurenine pathway (KP) alterations, fostering excitotoxicity and synaptic deficits. Translational studies demonstrate that elevated CRP and IL-6 predict poor antidepressant outcomes. Anti-inflammatory agents such as infliximab and celecoxib show efficacy in specific subgroups of patients. Emerging multi-omics approaches identify immuno-metabolic biotypes, supporting the rationale for biomarker-guided stratification. These findings define an 'inflammatory biotype' of mood disorders and highlight the need for biomarkers and precision-based trials to guide treatment.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/cells14191558
- Canonical
- link ↗
- Fetched
- 2026-11-07 MST
Cite this
APA
Pinzi, M., Fagiolini, A.M., Koukouna, D., Gualtieri, G., Rescalli, M.B., Pierini, C., Pardossi, S., Patrizio, B., & Cuomo, A. (2025). Inflammatory and Immune Biomarkers in Mood Disorders: From Mechanistic Pathways to Clinical Translation. <em>Cells</em>. https://doi.org/10.3390/cells14191558
Vancouver
Pinzi M, Fagiolini AM, Koukouna D, Gualtieri G, Rescalli MB, Pierini C, et al. Inflammatory and Immune Biomarkers in Mood Disorders: From Mechanistic Pathways to Clinical Translation. Cells. 2025. doi:10.3390/cells14191558.
BibTeX
@article{mario2025Inflam,
title = {Inflammatory and Immune Biomarkers in Mood Disorders: From Mechanistic Pathways to Clinical Translation},
author = {Mario Pinzi and Andrea M. Fagiolini and Despoina Koukouna and Giacomo Gualtieri and Maria Beatrice Rescalli and Caterina Pierini and Simone Pardossi and Benjamin Patrizio and Alessandro Cuomo},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14191558},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Clinical Medicine 2025
Open access · CC-BY
Unveiling the Interplay of EBV, HSV-1, and Inflammatory Biomarkers in Psychiatric Disorders
Brain Sciences 2026
Open access · CC-BY
Neuroinflammatory Mechanisms in Depression: From Biomarkers to Anti-Inflammatory Therapy
Research square 2026
Open access · OA
Cellular senescence changes and their association with brain structure in schizophrenia and major depressive disorder
Anesthesia & Analgesia 2021
Citation only
A Systematic Review and Meta-analysis Examining the Impact of Age on Perioperative Inflammatory Biomarkers
Frontiers in Aging Neuroscience 2010
Open access · CC-BY
Selective neuronal vulnerability to oxidative stress in the brain
Muscles (Basel, Switzerland) 2026
Open access · OA